Eton Pharmaceuticals (ETON) Total Non-Current Liabilities (2017 - 2025)

Eton Pharmaceuticals (ETON) has 5 years of Total Non-Current Liabilities data on file, last reported at $60.7 million in Q4 2025.

• For the quarter ending Q4 2025, Total Non-Current Liabilities rose 21.77% year-over-year to $60.7 million; the trailing twelve-month figure through Dec 2025 stood at $60.7 million (up 21.77% YoY), and the FY2025 full-year result was $60.7 million, up 21.77% from the prior year.
• Total Non-Current Liabilities eased to $60.7 million in Q4 2025, from $77.4 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $77.4 million in Q3 2025 to a low of $16.3 million in Q4 2023.
• A 3-year average of $55.5 million and a median of $58.1 million in 2025 frame the typical range for Total Non-Current Liabilities.
• Across the five-year window, Total Non-Current Liabilities surged 206.62% in 2024 and climbed 21.77% in 2025, its largest moves.
• Tracing ETON's Total Non-Current Liabilities over 3 years: stood at $16.3 million in 2023, then surged by 206.62% to $49.9 million in 2024, then gained by 21.77% to $60.7 million in 2025.
• Business Quant data shows ETON's Total Non-Current Liabilities at $60.7 million in Q4 2025, $77.4 million in Q3 2025, and $73.4 million in Q2 2025.